Bharat Parenterals share news, announcements and annual reports
NSE: BPLPHARMABSE: 541096Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,912.60.
30 Oct: open ₹2,277.90, high ₹2,295.10, low ₹1,955.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,399 Cr1,597th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 1,124.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.21
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.05%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.50
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,61,73927.6% delivered
Bharat Parenterals share news and announcements
386 announcements, routine notices left out, newest first. Page 4 of 8.
Apr 2024
29 Apr · Board meeting
25 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
25 Apr · Board meeting
Meeting on 29 Apr 2024: preferential issue of shares18 Apr · Corporate action
13 Apr · Compliances-Compliance Certificate For The Period Ended March, 2024.
Mar 2024
13 Mar · General Update About Company And Its Subsidiary Company
Feb 2024
22 Feb · Analysts
13 Feb · Results
Jan 2024
31 Jan · Board meeting
Meeting on 13 Feb 2024: quarterly results
Dec 2023
28 Dec · Legal
18 Dec · Legal
Exchange has sought clarification from Bharat Parenterals Ltd on December 18, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2023
1 Nov · Board meeting
Meeting on 9 Nov 2023: quarterly results
Oct 2023
2 Oct · Management
Sep 2023
30 Sep · Meeting
Aug 2023
1 Aug · Board meeting
Meeting on 9 Aug 2023: quarterly results
Jun 2023
7 Jun
May 2023
20 May · Board meeting
8 May · Board meeting
Meeting on 20 May 2023: final dividend, quarterly results and audited results
Apr 2023
25 Apr · Certificate Under Regulation 40(9) & (10) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, For The Year Ended 31St March, 2023
12 Apr · Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. For The Period Ended 31St March, 2023.
11 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2023
13 Feb · Board meeting
13 Feb · Board meeting
9 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Nov 2022
12 Nov · Board meeting
7 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
14 Oct · Sub: Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations')
11 Oct · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association